Learn more

HANGZHOU CHANGDIAN MEDICAL TECHNOLOGY CO LTD

Overview
  • Total Patents
    11
  • GoodIP Patent Rank
    174,063
About

HANGZHOU CHANGDIAN MEDICAL TECHNOLOGY CO LTD has a total of 11 patent applications. Its first patent ever was published in 2011. It filed its patents most often in China. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are ADORX THERAPEUTICS LTD, DONAU PHARMAZIE G M B H and GALENIKA PHARMACEUTICAL.

Patent filings in countries

World map showing HANGZHOU CHANGDIAN MEDICAL TECHNOLOGY CO LTDs patent filings in countries
# Country Total Patents
#1 China 11

Patent filings per year

Chart showing HANGZHOU CHANGDIAN MEDICAL TECHNOLOGY CO LTDs patent filings per year from 1900 to 2020

Focus industries

Focus technologies

Top inventors

# Name Total Patents
#1 Fu Miaoqing 11
#2 Li Fengsheng 9
#3 Chen Yudong 6
#4 Li Dazhong 5
#5 Chen Zongdong 3
#6 Jiang Linhai 1
#7 Fu Genyuan 1
#8 Hu Guosheng 1
#9 Zhou Baishui 1

Latest patents

Publication Filing date Title
CN104193767A Cefamandole nafate superfine powder preparation and preparation method thereof
CN104045656A Cefoxitin sodium superfine-powder preparation and preparation method thereof
CN104042563A Ceftizoxime sodium ultrafine powder preparation and preparation method thereof
CN104161729A Special ultrafine potassium sodium dehydroandroandrographolide succinate powder preparation and preparation method thereof
CN104163781A Special ultrafine tiopronin powder lyophilized preparation and preparation method thereof
CN104163822A Special ultrafine cefmetazole sodium powder preparation and preparation method thereof
CN104127387A Special ultrafine omeprazole sodium powder freeze-dried preparation and preparation method thereof
CN104127388A Special ultrafine carbazochrome sodium sulfonate powder freeze-dried preparation and preparation method thereof
CN104856997A Special piperacillin sodium-tazobactam sodium ultra-fine powder preparation and preparation method thereof
CN103083351A Pharmaceutical composite preparation of water-soluble vitamin for injection and fat-soluble vitamin injection
CN103071145A N(2)-L-alanyl-L-glutamine/compound amino acid injection (18AA-V) pharmaceutical composite preparation